Discovery of a new drug using lipid-based formulation targeting G12D mutated KRAS4B through non-covalent bonds https://www.biorxiv.org/content/10.1101/2023.04.05.535682v1?med=mas
Discovery of a new drug using lipid-based formulation targeting G12D mutated KRAS4B through non-covalent bonds https://www.biorxiv.org/content/10.1101/2023.04.05.535682v1?med=mas